The investigational anti-amyloid drug donanemab (Eli Lilly) has similar clinical efficacy in apolipoprotein E ε4 (APOE4) heterozygous and homozygous carriers ...
Even at an advanced age, superagers have the memory of someone 20 or 30 years their junior. But why is ...
The FDA today approved a new therapy for early Alzheimer's disease that appears to modestly slow the progression of the ...
Short-term and cyclical use of estrogen and progestin therapy for menopausal symptoms is linked to an increased risk of dementia, ...
The anti-amyloid agent lecanemab (Leqembi, Eisai) and associated ancillary services could add an estimated $2 to $5 billion annually to ...
When screening patients for dementia, incorporating standard retinal imaging into an assessment of traditional risk factors for the disease can ...
An insomnia medication has been linked to lower levels of Alzheimer's disease (AD) pathology in humans, results of a small ...
By Cara Murez HealthDay ReporterWEDNESDAY, April 5, 2023 (HealthDay News) -- A new national Alzheimer’s disease and dementia database could be ...
While recent studies have suggested a decrease in the incidence of clinical dementia in the United States, there does not ...
Sustaining even a single head injury has been linked to a significantly increased risk of all-cause mortality in new research. An ...
© Pharma News Hubb All rights reserved.
Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.